McFarlane Neil F.
President and CEO
McFarlane Neil F. has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 10, 2026.
On the most recent filing, McFarlane Neil F. is listed as President and CEO at ZEVRA THERAPEUTICS, INC. Inside the rolling window, McFarlane Neil F. reported no open-market purchases and 3 open-market sales totaling $1.2M in ZVRA. The largest disclosed transaction in the window is a sale of 91,000 ZVRA shares on Feb 2, 2026, worth $853K.
Companies traded
Other insiders at ZVRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has McFarlane Neil F. made?
McFarlane Neil F. has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does McFarlane Neil F. trade?
McFarlane Neil F. has filed SEC Form 4 disclosures for 1 company, including ZVRA.
When was McFarlane Neil F.'s most recent SEC Form 4 filing?
McFarlane Neil F.'s most recent SEC Form 4 filing on Tracefour is dated Feb 10, 2026.
What is McFarlane Neil F.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, McFarlane Neil F. is listed as President and CEO.
What is McFarlane Neil F.'s total buy and sell value in the current window?
Inside the rolling retention window, McFarlane Neil F. bought $0 and sold $1.2M based on SEC Form 4 filings.
What was McFarlane Neil F.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 91,000 ZVRA shares on 2026-02-02, worth $853K, per SEC Form 4 filings.